Mr. Shane Madden reports

HYDREIGHT TECHNOLOGIES INC. ANNOUNCES CLOSING OF $5.4 MILLION LIFE OFFERING

Hydreight Technologies Inc., further to the news releases of the company dated Feb. 10, 2025, and Feb. 18, 2025, has closed its previously announced commercially reasonable best efforts private placement, with Beacon Securities Ltd. acting as the sole agent. The company issued 3,492,300 units of the company at a price of $1.55 per unit for aggregate gross proceeds of $5,413,065. The offering was conducted pursuant to an agency agreement dated Feb. 26, 2025, between the company and the agent. Shane Madden, the chief executive officer of the company, commented: "The company greatly appreciates the support of the market and is extremely happy to see such strong institutional investor demand in the offering, which has exceeded managements' initial expectations. We continue to focus on the company's growth and profitability."

The terms of the offering consisted of the sale of up to 2,581,000 units, subject to an option of the agent to increase the number of offered units by up to an additional 3.71 million units. The agent's option was exercised for a total of 911,300 additional units. The units were issued pursuant to the listed issuer financing exemption (LIFE) under Part 5A of National Instrument 45-106, Prospectus Exemptions.

Each unit consists of one common share in the capital of the company and one common share purchase warrant of the company. The warrants were issued pursuant to a warrant indenture dated Feb. 26, 2025, between the company and Odyssey Trust Company as warrant agent, and each warrant entitles the holder thereof to acquire one common share of the company at a price of $2 per warrant share for a period of 36 months from the closing date of the offering.

As consideration for acting as agent, the agent received: (i) a cash commission of $257,823.90; (ii) a corporate finance fee of $70,297.50; and (iii) 209,538 non-transferable compensation options, exercisable for a period of 24 months following the closing date to acquire, in aggregate, that number of common shares in the capital of the company at an exercise price equal to $1.55 per compensation option share.

The securities issued under the listed issuer financing exemption, including the unit shares and any warrant shares, are not subject to a hold period pursuant to applicable Canadian securities laws.

The company intends to use the net proceeds raised from the offering to support sales growth and for working capital and general corporate purposes as further described in the company's offering document under the listed issuer financing exemption dated Feb. 10, 2025.

About Hydreight Technologies Inc.

Hydreight Technologies is building one of the largest mobile clinic networks in the United States. Its proprietary, fully integrated platform hosts a network of over 2,500 nurses, over 100 doctors and a pharmacy network across 50 states. The platform includes a built-in, easy-to-use suite of fully integrated tools for accounting, documentation, sales, inventory, booking and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians and other licensed health care professionals. The Hydreight platform allows health care professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. Hydreight has a 503B pharmacy network servicing all 50 states and is closely affiliated with a U.S. certified e-script and telemedicine provider network.